Compound details
Silibinin
| Compound ID | CDAMM01375 |
|---|---|
| Common name | Silibinin | IUPAC name | 3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one |
| Molecular formula | C25H22O10 |
| Retention time | 14.72 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 483.122 | Theoretical mz | 483.128 |
| Error | 12.16 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.4642 |
| Inchi key | SEBFKMXJBCUCAI-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C1C=2C(O)=CC(O)=CC2OC(C3=CC=C4OC(CO)C(OC4=C3)C5=CC=C(O)C(OC)=C5)C1O |
| Superclass | Lignans, neolignans and related compounds |
| Class | Flavonolignans |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q12809 | KCNH2 | HERG | T20251 | SwissTargetPrediction |
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction and SEA |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P05067 | APP | Beta amyloid A4 protein | T87024 | SwissTargetPrediction |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SwissTargetPrediction and SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SwissTargetPrediction and SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SwissTargetPrediction and SEA |
| P27338 | MAOB | Monoamine oxidase B | T83011 | SwissTargetPrediction |
| P14867 | GABRA1 | GABA-A receptor; alpha-1/beta-2/gamma-2 | T51487 | SwissTargetPrediction |
| Q5T7T8 | COX1 | Prostaglandin G/H synthase 1 | T60529 | SwissTargetPrediction |
| P11926 | ODC1 | Ornithine decarboxylase | T60366 | SEA |
| P35968 | KDR | Vascular endothelial growth factor receptor 2 | T80975 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| O14842 | FFAR1 | Free fatty acid receptor 1 | T25608 | SwissTargetPrediction |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SwissTargetPrediction |
| Q14534 | SQLE | Squalene monooxygenase (by homology) | T93344 | SwissTargetPrediction |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction |
| P56817 | BACE1 | Beta-secretase 1 | T79031 | SwissTargetPrediction |
| P45452 | MMP13 | Matrix metalloproteinase 13 | T34296 | SwissTargetPrediction |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| O14746 | TERT | Telomerase reverse transcriptase | T86052 | SwissTargetPrediction |
| P08581 | MET | Hepatocyte growth factor receptor | T40474 | SwissTargetPrediction |
| P10721 | KIT | Stem cell growth factor receptor | T57700 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P06870 | KLK1 | Kallikrein 1 | T40000 | SwissTargetPrediction |
| P20151 | KLK2 | Kallikrein 2 | T01908 | SwissTargetPrediction and SEA |
| P11362 | FGFR1 | Fibroblast growth factor receptor 1 | T47101 | SwissTargetPrediction |
| P39900 | MMP12 | Matrix metalloproteinase 12 | T03500 | SwissTargetPrediction |
| P19793 | RXRA | Retinoid X receptor alpha (by homology) | T13726 | SwissTargetPrediction |
| P50281 | MMP14 | Matrix metalloproteinase 14 | T65019 | SwissTargetPrediction |
| P10415 | BCL2 | Apoptosis regulator Bcl-2 | T31309 | SwissTargetPrediction |
| P52209 | PGD | 6-phosphogluconate dehydrogenase | T76497 | SwissTargetPrediction and SEA |
| P22083 | FUT4 | Fucosyltransferase 4 | T51146 | SwissTargetPrediction |
| P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | T64205 | SwissTargetPrediction |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SwissTargetPrediction and SEA |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SwissTargetPrediction and SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SwissTargetPrediction and SEA |
| P05231 | IL6 | Interleukin-6 | T32578 | SEA |
| P00740 | F9 | Coagulation factor IX | T83369 | SwissTargetPrediction |
| Q92887 | CMOAT | Multidrug resistance-associated protein 2 | T61792 | SEA |
| Q8N183 | NDUFAF2 | HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2 | T01453 | SEA |
| Q9P0J0 | NDUFA13 | Mitochondrial complex I | T82391 | SEA |
| Q9Y6M9 | NDUFB9 | HUMAN NADH:ubiquinone oxidoreductase subunit B9 | T01465 | SEA |
| Q8N183 | NDUFAF2 | HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2 | T01453 | SEA |
| P03897 | MT-ND3 | NADH dehydrogenase | T77195 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T20251 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q12809 | KCNH2 |
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T51487 | DI0014 | Acute respiratory distress syndrome | [ICD-11: CB00] | P14867 | GABRA1 |
| T51487 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P14867 | GABRA1 |
| T51487 | DI0082 | Chronic insomnia | [ICD-11: 7A00] | P14867 | GABRA1 |
| T51487 | DI0087 | Chronic pain | [ICD-11: MG30] | P14867 | GABRA1 |
| T51487 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P14867 | GABRA1 |
| T51487 | DI0112 | Cystitis | [ICD-11: GC00] | P14867 | GABRA1 |
| T51487 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14867 | GABRA1 |
| T51487 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P14867 | GABRA1 |
| T51487 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P14867 | GABRA1 |
| T51487 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14867 | GABRA1 |
| T51487 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P14867 | GABRA1 |
| T51487 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P14867 | GABRA1 |
| T51487 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P14867 | GABRA1 |
| T60529 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | Q5T7T8 | COX1 |
| T60529 | DI0145 | Female pelvic pain | [ICD-11: GA34] | Q5T7T8 | COX1 |
| T60529 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q5T7T8 | COX1 |
| T60529 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | Q5T7T8 | COX1 |
| T60529 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q5T7T8 | COX1 |
| T60529 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q5T7T8 | COX1 |
| T60529 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q5T7T8 | COX1 |
| T60529 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q5T7T8 | COX1 |
| T60529 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q5T7T8 | COX1 |
| T60529 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | Q5T7T8 | COX1 |
| T60529 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | Q5T7T8 | COX1 |
| T60529 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | Q5T7T8 | COX1 |
| T60366 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | P11926 | ODC1 |
| T80975 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P35968 | KDR |
| T80975 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P35968 | KDR |
| T80975 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P35968 | KDR |
| T80975 | DI0244 | Malignant digestive organ neoplasm | [ICD-11: 2C11] | P35968 | KDR |
| T80975 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P35968 | KDR |
| T80975 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35968 | KDR |
| T80975 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P35968 | KDR |
| T80975 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P35968 | KDR |
| T80975 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P35968 | KDR |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T25608 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | O14842 | FFAR1 |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T93344 | DI0118 | Dermatophytosis | [ICD-11: 1F28] | Q14534 | SQLE |
| T93344 | DI0385 | Skin fungal infection disorder | [ICD-11: EA60] | Q14534 | SQLE |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T79031 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P56817 | BACE1 |
| T34296 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45452 | MMP13 |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T86052 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | O14746 | TERT |
| T86052 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O14746 | TERT |
| T86052 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14746 | TERT |
| T40474 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P08581 | MET |
| T57700 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P10721 | KIT |
| T57700 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P10721 | KIT |
| T57700 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P10721 | KIT |
| T57700 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P10721 | KIT |
| T57700 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P10721 | KIT |
| T57700 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P10721 | KIT |
| T57700 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P10721 | KIT |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T01908 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | P20151 | KLK2 |
| T47101 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P11362 | FGFR1 |
| T47101 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P11362 | FGFR1 |
| T47101 | DI0235 | Liver cancer | [ICD-11: 2C12] | P11362 | FGFR1 |
| T47101 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P11362 | FGFR1 |
| T03500 | DI0037 | Asthma | [ICD-11: CA23] | P39900 | MMP12 |
| T03500 | DI0238 | Lung cancer | [ICD-11: 2C25] | P39900 | MMP12 |
| T03500 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P39900 | MMP12 |
| T13726 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P19793 | RXRA |
| T13726 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P19793 | RXRA |
| T65019 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P50281 | MMP14 |
| T31309 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10415 | BCL2 |
| T31309 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P10415 | BCL2 |
| T31309 | DI0273 | Motor neuron disease | [ICD-11: 8B60] | P10415 | BCL2 |
| T31309 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P10415 | BCL2 |
| T76497 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P52209 | PGD |
| T51146 | DI0441 | Appendicitis | [ICD-11: DB10] | P22083 | FUT4 |
| T64205 | DI0383 | Skin and skin-structure infection | [ICD-11: 1F28-1G0Z] | P42224 | STAT1 |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |
| T32578 | DI0028 | Anemia | [ICD-11: 3A00-3A9Z] | P05231 | IL6 |
| T83369 | DI0052 | Bleeding disorder | [ICD-11: GA20-GA21] | P00740 | F9 |
| T83369 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00740 | F9 |
| T82391 | DI0069 | Cardiomyopathy | [ICD-11: BC43] | Q9P0J0 | NDUFA13 |
| T77195 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P03897 | MT-ND3 |